Renal angiomyoadenomatous tumor: Fluorescence in situ hybridization

Pathology International

Volumn 59, Issue 9, 2009, Pages 689-691

  Kuroda, Naoto ^a   Michal, Michal ^b   Hes, Ondrej ^b   Taguchi, Takahiro ^c   Tominaga, Akira ^c   Mizobuchi, Kohichi ^d   Ohe, Chisato ^e   Sakaida, Noriko ^e   Uemura, Yoshiko ^e   Shuin, Taro ^a   Lee, Gang Hong ^a  

^a KOCHI UNIVERSITY   (Japan)

^b CHARLES UNIVERSITY   (Czech Republic)

^c KOCHI UNIVERSITY   (Japan)

^d KAGAWA ROSAI HOSPITAL   (Japan)

^e KANSAI MEDICAL UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOSOME 1; CHROMOSOME 11; CHROMOSOME 16; CHROMOSOME ABERRATION; CHROMOSOME LOSS; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; KIDNEY ANGIOMYOADENOMATOUS TUMOR; KIDNEY CARCINOMA; KIDNEY TUMOR; LETTER; MONOSOMY; ONCOCYTOMA; PRIORITY JOURNAL; TUMOR CELL; Y CHROMOSOME;

ANGIOMYOMA; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 16; DNA, NEOPLASM; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KIDNEY NEOPLASMS; MONOSOMY;

EID: 68949113722     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2009.02429.x     Document Type: Letter

References (18)

1. Michal M, Hes O, Havlicek F. Benign renal angiomyoadenomatous tumor: A previously unreported renal tumor. Ann Diagn Pathol 2000 15 : 311 15.
2. Michal M, Hes O, Nemcova J et al. Renal angiomyoadenomatous tumor: Morphologic, immunohistochemical and molecular genetic study of a new entity. Virchows Arch 2009 454 : 89 99.
3. Iqbal MA, Akhtar M, Al Dayel F, Ulmer C, Paterson MC. Use of FISH analysis of renal cell carcinoma subtypes. Ann Saudi Med 1999 19 : 495 500.
4. Sanjmyatav J, Rubtsov N, Starke H, Schubert J, Hindermann W, Junker K. Identification of tumor entities of renal cell carcinoma using interphase fluorescence in situ hybridization. J Urol 2005 174 : 731 5.
5. Barocas DA, Mathew S, DelPizzo J.J et al. Renal cell carcinoma sub-typing by histopathology and fluorescence in situ hybridization on a needle biopsy specimen. BJU Int 2007 99 : 290 95.
6. Brunelli M, Eble JN, Zhang S, Martignoni G, Cheng L. Gains of chromosomes 7, 17, 12, 16, and 20 and loss of Y occur early in the evolution of papillary renal cell neoplasia: A fluorescence in situ hybridization study. Mod Pathol 2003 16 : 1053 9.
7. Hes O, Brunelli M, Michal M et al. Oncocytic papillary renal cell carcinoma: A clinicopathologic, immunohistochemical, ultrastructural, and interphase cytogenetic study of 12 cases. Ann Diag Pathol 2006 10 : 133 9.
8. Brunelli M, Eble JN, Zhang S, Martignoni G, Delahunt B, Cheng L. Eosinophilic and classic chromophobe renal cell carcinomas have similar frequent losses of multiple chromosomes from among chromosomes 1, 2, 6, 10, 17, and this pattern of genetic abnormality is not present in renal oncocytoma. Mod Pathol 2005 18 : 161 9.
9. Hes O, Vanecek T, Perez-Montiel DM et al. Chromophobe renal cell carcinoma with microcystic and adenomatous arrangement and pigmentation: A diagnostic pitfall. Morphological, immunohistochemical, ultrastructural and molecular genetic report of 20 cases. Virchows Arch 2005 446 : 383 93.
10. Kuroda N, Katto K, Yamaguchi T et al. Chromophobe renal cell carcinoma: Useful diagnostic application of imprint cytology and fluorescence in situ hybridization of chromosomes 10 and 21 in two cases of typical and eosinophilic variants. Med Mol Morphol 2008 41 : 227 32.
11. Parker R, Reeves HM, Sudarshan S, Wolff D, Keane T. Abnormal fluorescence in situ hybridization analysis in collecting duct carcinoma. Urology 2005 66 : 1110.
12. Cossu-Rocca P, Eble JN, Delahunt B et al. Renal mucinous tubular and spindle cell carcinoma lacks the gains of chromosomes 7 and 17 and losses of Y chromosome that are prevalent in papillary renal cell carcinoma. Mod Pathol 2006 19 : 488 93.
13. Kuroda N, Hes O, Michal M et al. Mucinous tubular and spindle cell carcinoma with Fuhrman nuclear grade 3: A histological, immunohistochemical, ultrastructural and FISH study. Histol Histopathol 2008 23 : 1512 23.
14. Brandal P, Lie AK, Bassarova A et al. Genomic aberrations in mucinous tubular and spindle cell renal cell carcinomas. Mod Pathol 2006 19 : 186 94.
15. Al-Saleem T, Balsara BR, Liu Z et al. Renal oncocytoma with loss of chromosome Y and 1 evolving to papillary carcinoma in connection with gain of chromosome 7. Coincidence or progression? Cancer Genet Cytogenet 2005 163 : 81 5.
16. Brown JA, Anderl KL, Borell TJ, Qian J, Bostwick DG, Jenkins RB. Simultaneous chromosome 7 and 17 gain and sex chromosome loss provide evidence that renal metanephric adenoma is related to papillary renal cell carcinoma. J Urol 1997 158 : 370 74.
17. Renshaw AA, Maurici D, Fletcher JA. Cytologic and fluorescence in situ hybridization (FISH) examination of metanephric adenoma. Diagn Cytopathol 1997 16 : 107 11.
18. Brunelli M, Eble JN, Zhang S, Martignoni G, Cheng L. Metanephric adenoma lacks the gains of chromosomes 7 and 17 and loss of Y that are typical of papillary renal cell carcinoma and papillary adenoma. Mod Pathol 2003 16 : 1060 63.